simendan has been researched along with Anoxemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aalto-Setälä, K; Gaballah, M; Kallio, P; Kreutzer, J; Mäki, AJ; Penttinen, K | 1 |
| Bauer, I; Beck, C; Picker, O; Vollmer, C; Weiß, S | 1 |
| Picker, O; Schober, P; Schwarte, LA; Schwartges, I; Thomas, K | 1 |
| Bocchi, EA; Carvalho, VO; Cruz, F; Guimarães, GV; Issa, VS; Moura, LZ | 1 |
| Kylhammar, D; Rådegran, G; Wiklund, A | 1 |
| Bigam, DL; Cheung, PY; Churchill, T; Joynt, C; Manouchehri, N; Vento, M | 1 |
1 trial(s) available for simendan and Anoxemia
| Article | Year |
|---|---|
Effects of the recombinant form of the natural human B-type natriuretic peptide and levosimendan on pulmonary hyperventilation and chemosensivity in heart failure.
Topics: Adult; Brazil; Cardiovascular Agents; Chemoreceptor Cells; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Hypercapnia; Hyperventilation; Hypoxia; Infusions, Intravenous; Lung; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyridazines; Recombinant Proteins; Respiratory Rate; Simendan; Time Factors; Treatment Outcome | 2013 |
5 other study(ies) available for simendan and Anoxemia
| Article | Year |
|---|---|
Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cells, Cultured; Humans; Hypoxia; Induced Pluripotent Stem Cells; Ischemia; Lab-On-A-Chip Devices; Myocardial Ischemia; Myocytes, Cardiac; Simendan | 2022 |
Hypothermia improves oral and gastric mucosal oxygenation during hypoxic challenges.
Topics: Animals; Cardiac Output; Cardiotonic Agents; Cross-Over Studies; Disease Models, Animal; Dogs; Female; Gastric Mucosa; Glyburide; Hydrazones; Hypoglycemic Agents; Hypothermia, Induced; Hypoxia; Laser-Doppler Flowmetry; Microcirculation; Mouth Mucosa; Oxygen; Pyridazines; Simendan | 2014 |
The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia.
Topics: Acute Disease; Adenosine Triphosphate; Animals; Dogs; Glyburide; Hemodynamics; Hydrazones; Hypoglycemic Agents; Hypoxia; Metabolism; Microcirculation; Models, Animal; Pyridazines; Simendan; Vasodilator Agents | 2011 |
Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Female; Heart Rate; Hydrazones; Hypertension, Pulmonary; Hypoxia; Oxygen Consumption; Pyridazines; Simendan; Swine; Time Factors; Vascular Resistance | 2012 |
Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine.
Topics: Animals; Animals, Newborn; Cardiotonic Agents; Dopamine; Drug Therapy, Combination; Hemodynamics; Hydrazones; Hypoxia; Mesenteric Arteries; Milrinone; Models, Animal; Myocardial Reperfusion; Myocardial Reperfusion Injury; Oxidative Stress; Pyridazines; Simendan; Swine; Vasodilator Agents | 2012 |